Abstract

Carbidopa 1.25-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2007 - Pediatric Patients

Page(s): 70

Download in electronic PDF format for $75

Abstract

A formulation for preparing Carbidopa 1.25-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2007 Pg. 70	Carbidopa 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 145	Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 149	Levodopa and Carbidopa Rectal Suspension Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 6-8	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Sep/Oct 2009 Pg. 386-389	Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Author(s): Williams LaVonn A, Fokken Dawn
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2002 Pg. 202	Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 410	Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 421	Metoprolol Tartrate 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 276-279	Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Author(s): Glasnapp Andrew, Schaefer Erin
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Jul/Aug 2003 Pg. 304	Triprolidine HCl 1.25-mg/5-mL, Pseudoephedrine HCl 30-mg/5-mL and Codeine Phosphate 10-mg/5-mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 220-225	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Nov/Dec 2019 Pg. 487	Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 229	Prednisolone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 435-437	Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations Author(s): Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia